Recommended videos
AZZ Incorporated (NYSE:AZZ)
74 views
15 éve
(SPA, BLRX, SURW) CRWENewswire
8 views
14 éve
TEAR, BLRX, PLCM) CRWENewswire
17 views
14 éve
Threshold Pharmaceuticals THLD
20 views
14 éve
KORS, SNSS, ADEP) CRWENewswire
21 views
14 éve
(BDSI, AZZ, GBX) CRWENewswire
13 views
BioDelivery Sciences International Inc - BDSI - reported the signing of a worldwide license and development agreement with Endo Pharmaceuticals for the exclusive rights to develop and commercialize BEMA Buprenorphine for the treatment of chronic pain. In aggregate, the agreement is worth up to $180 million to BioDelivery Sciences if all milestones are met.
Date:
2012. 01. 06.
Add to list
Recommended videos
(VRNM, ALGN, GGS) CRWENewswire
12 views
14 éve
(CACI, ATHX, ORN) CRWENewswire
13 views
14 éve
(HAL, CRWE, TBAC) CRWENewswire
9 views
14 éve
MOSY, DYSL, STAN) CRWENewswire
14 views
14 éve
(PANL, CFI, CO) CRWENewswire
22 views
15 éve
CSC Gets $200M Contract
14 views
14 éve
(RMBS, CMG, HII) CRWENewswire
81 views
14 éve
Tetra Tech TTEK $55M Contract
8 views
14 éve

(VRNM, ALGN, GGS) CRWENewswire
12 views
14 éve
(CACI, ATHX, ORN) CRWENewswire
13 views
14 éve
(HAL, CRWE, TBAC) CRWENewswire
9 views
14 éve
MOSY, DYSL, STAN) CRWENewswire
14 views
14 éve
(PANL, CFI, CO) CRWENewswire
22 views
15 éve
CSC Gets $200M Contract
14 views
14 éve
(RMBS, CMG, HII) CRWENewswire
81 views
14 éve
Tetra Tech TTEK $55M Contract
8 views
14 éve
Facebook
X / Twitter
Tumblr
Reddit
Telegram
WhatsApp
LinkedIn
E-mail